CLINIGMA^® Insights

We're not just service providers—we're active contributors to advancing patient-centered drug development. By sharing our insights, challenges, and solutions, we help elevate industry standards and ensure more patients worldwide have their voices heard.

Optimizing safety reporting for in-trial patient interviews

Patient interviews provide invaluable insights in clinical trials—but when participants mention potential side effects, how should researchers handle safety reporting?

Planning COA strategy for patient focused drug development

Most pharmaceutical companies think they know what matters to patients—but without the right COA strategy, you might be measuring the wrong things entirely.

Managing the human factor: navigating challenges in patient interviews

Scheduling mix-ups and confidentiality issues can impact patient interviews—but the right systems and flexibility help maintain trial integrity.

Centering patients for new cancer drug development

FDA guidance is putting patient experience data at the center of drug development—but most oncology companies still don't know how to capture what actually matters to patients.

CLINIGMA® Insights

Optimizing safety reporting for in-trial patient interviews

Planning COA strategy for patient focused drug development

Managing the human factor: navigating challenges in patient interviews

Centering patients for new cancer drug development

Stay informed. Stay engaged. Make a difference.

CLINIGMA^® Insights